The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by SACHSSE, U.
* Articles by HUETHER, G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by SACHSSE, U.
* Articles by HUETHER, G.
Related Collections
* Borderline Personality Disorders
* Stress
* Other Violence/Aggression
* Antidepressants
* Other Neuroleptics
Am J Psychiatry 159:672, April 2002
© 2002 American Psychiatric Association


Letter to the Editor

Stress Regulation and Self-Mutilation

ULRICH SACHSSE, M.D., SUSANNE VON DER HEYDE, M.D., and GERALD HUETHER, PH.D.
Goettingen, Germany

To the Editor: We studied the relationship between acts of self-mutilation and fluctuations in levels of nocturnal urinary cortisol excretion in a female inpatient who developed borderline personality disorder after traumatization during childhood.

Ms. A, a 36-year-old woman, had pronounced repetitive self-mutilating behavior in addition to borderline personality disorder diagnosed according to an interview with the German version of the Dissociative Disorders Interview Schedule (1) (DSM-IV diagnoses 296.32, 300.6, 300.12, 300.15, 300.81, 301.83, and 307.1). She collected her entire nocturnal (8:00 p.m. to 8:00 a.m.) urine output on 86 consecutive nights (2) Her nocturnal urinary volumes were almost identical (mean=983 ml, SD=128), but the fluctuations in her nocturnal cortisol excretion were extreme, varying from 2 to 30 µg a night. Compared to normative data (cortisol excretion during 24 hours: 20–90 µg/day), her nocturnal cortisol secretion appears low on average; this is in accordance with data from other studies (3). However, our longitudinal study revealed that periods of low cortisol excretion were followed by periods of continuous increases in excretion over several nights. Above 20 µg a night, she performed one or several acts of self-mutilation. Subsequently, an instantaneous decrease to low initial baseline values of cortisol was observed. Thereafter, her nocturnal cortisol excretion remained at this low level for several days. The next period of increasing cortisol secretion was again terminated by an episode of self-mutilation.

It has long been speculated that self-mutilating behavior serves a coping function that is activated by an increase in emotional arousal (4, 5). Between 1 and 3 days before an episode of self-mutilating behavior, our patient reported increasing feelings of dissociation and depersonalization, flashbacks, and depressive states that were difficult to control either by herself or by therapeutic interventions. It seems that above a critical excitation threshold, Ms. A coped with escalating arousal with self-mutilating behavior.

We believe that our results provide the first empirical demonstration that episodes of self-mutilating behavior occur in response to hyperactivity of the central stress-sensitive neuroendocrine systems and increased cortisol secretion. Further longitudinal studies are needed to confirm this finding. Observations in nonhuman mammals have shown that self-mutilating behaviors may emerge as a consequence of deprived rearing conditions (6, 7). Thus, self-mutilating behavior may be regarded as an unusual but effective coping strategy for the self-regulation of hyperarousal and/or dissociative states and for regaining control over an otherwise uncontrollable stress response (8).

References

  1. Ross CA, Heber S, Norton GR, Anderson D, Anderson G, Burchet P: The Dissociative Disorders Interview Schedule: a structured interview. Dissociation 1989; 2:169-189
  2. Adler L, Wedekind D, Pilz J, Weniger G, Huether G: Endocrine correlates of personality traits: a comparison between emotionally stable and emotionally labile healthy young men. Neuropsychobiology 1997; 35:205-210[Medline]
  3. Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW: Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 1991; 30:1031-1048[CrossRef][Medline]
  4. Winchel RM, Stanley M: Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am J Psychiatry 1991; 148:306-317[Abstract/Free Full Text]
  5. van der Kolk BA, Perry JC, Herman JL: Childhood origins of self-destructive behavior. Am J Psychiatry 1991; 148:1665-1671[Abstract/Free Full Text]
  6. Jones IH: Self-injury: toward a biological basis. Perspect Biol Med 1982; 26:137-150[Medline]
  7. Kraemer GW, Clarke AS: The behavioral neurobiology of self-injurious behavior in rhesus monkeys. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14(suppl):S141-S168
  8. Huether G: The central adaptation syndrome: psychosocial stress as a trigger for adaptive modifications of brain structure and brain function. Prog Neurobiol 1996; 48:569-612[CrossRef][Medline]



This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
C. J Lim, C. Trevino, and R. R Tampi
Can Olanzapine Cause Delirium in the Elderly?
Ann. Pharmacother., January 1, 2006; 40(1): 135 - 138.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Basu, P. K. Gillman, N. Gnanadesigan, R. T. Espinoza, R. L. Smith, J. A.H.R. Claassen, H. P.M.M. Gelissen, E. W. Boyer, and M. Shannon
The Serotonin Syndrome
N. Engl. J. Med., June 9, 2005; 352(23): 2454 - 2456.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
H. S. DUGGAL and J. KITHAS
Possible Neuroleptic Malignant Syndrome With Aripiprazole and Fluoxetine
Am J Psychiatry, February 1, 2005; 162(2): 397 - 398.
[Full Text] [PDF]


Home page
CMAJHome page
M. E. Cates
Ziprasidone -- not an option for serotonin syndrome
Can. Med. Assoc. J., November 25, 2003; 169(11): 1147 - 1148.
[Full Text] [PDF]


This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by SACHSSE, U.
* Articles by HUETHER, G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by SACHSSE, U.
* Articles by HUETHER, G.
Related Collections
* Borderline Personality Disorders
* Stress
* Other Violence/Aggression
* Antidepressants
* Other Neuroleptics


Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org